Chemomab Therapeutics(CMMB) - 2025 Q2 - Quarterly Report

Exhibit 99.1 Chemomab Therapeutics Ltd. and its subsidiaries Interim Condensed Consolidated Financial Statements As of June 30, 2025 (Unaudited) Chemomab Therapeutics Ltd. and its subsidiaries Interim Condensed Consolidated Financial Statements as of June 30, 2025 (Unaudited) (*) 1 American Depositary Share (ADS) represents 20 Ordinary Shares 3 Contents | | Page | | --- | --- | | Interim Condensed Consolidated Balance Sheets | 3 | | Interim Condensed Consolidated Statements of Operations | 4 | | Interim Con ...